| For: | Pan SD, Xiong CY, Shen YJ, Tian JH, Wang YL, Wang JN, Wang SY, Li FY, Wang LF, Qiu Q, Yang L, Liu XM, Luan JQ, Zou ZS, Wang FS, Meng FP. MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid. World J Gastroenterol 2025; 31(31): 109828 [PMID: 40901689 DOI: 10.3748/wjg.v31.i31.109828] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i31/109828.htm |
| Number | Citing Articles |
| 1 |
Terence N. Moyana. Primary Biliary Cholangitis—The Changing Biomarker Paradigms for Staging Fibrosis. Livers 2026; 6(2) doi: 10.3390/livers6020023
|
| 2 |
Yi-Fei Yang, Qi-Xuan Liu, Wen-Hao Su, Bo Zang, Bing-Qian Liu, Chen-Yang Zhao, Yi-Bing Han, Ling-Wei Liu, Patrick S C Leung, Bin Liu. Plasma exosomal miR-137 activates natural killer cells in primary biliary cholangitis by targeting <i>NFATC1</i>. World Journal of Hepatology 2026; 18(6): 116738 doi: 10.4254/wjh.116738
Abstract(26) |
Core Tip(42) |
Full Article(HTML)(53)
|
Full Article (PDF)-5518K(24)
|
Full Article with Cover (PDF)-5755K(10)
|
Full Article (XML)-114K(11)
|
Audio-396K(2)
|
Peer-Review Report-468K(15)
|
Answering Reviewers-210K(12)
|
Supplementary Material-156K(8)
|
Times Cited (0)
|
Total Visits (136)
|
Open
|